Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMIC, OTICGeneric

HYDELTRASOL

PREDNISOLONE SODIUM PHOSPHATE

Standard Dose
EQ 0.25% PHOSPHATE
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview HYDELTRASOL is listed in Drugs@FDA under application 011028 (NDA).

Marketing status: Discontinued Active ingredient PREDNISOLONE SODIUM PHOSPHATE Form and strength OINTMENT;OPHTHALMIC, OTIC - EQ 0.25% PHOSPHATE Sponsor MERCK Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview HYDELTRASOL is listed in Drugs@FDA under application 011028 (NDA). Marketing status: Discontinued Active ingredient PREDNISOLONE SODIUM PHOSPHATE Form and strength OINTMENT;OPHTHALMIC, OTIC - EQ 0.25% PHOSPHATE Sponsor MERCK Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.